ALPS Medical Breakthroughs ETF (SBIO)
NYSEARCA: SBIO · Real-Time Price · USD
56.67
+0.51 (0.91%)
Apr 15, 2026, 4:00 PM EDT - Market closed
SBIO Holdings Information
SBIO is an equity ETF with a total of 89 individual holdings. The top holdings are Kymera Therapeutics stock at 4.22%, Mirum Pharmaceuticals at 3.36%, CG Oncology at 3.26%, Alkermes at 3.24%, and Celcuity at 3.21%.
Total Holdings
89
Top 10 Percentage
31.48%
Asset Class
Equity
ETF Category
Health
Assets
136.05M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | KYMR | Kymera Therapeutics, Inc. | 4.22% |
| 2 | MIRM | Mirum Pharmaceuticals, Inc. | 3.36% |
| 3 | CGON | CG Oncology, Inc. | 3.26% |
| 4 | ALKS | Alkermes plc | 3.24% |
| 5 | CELC | Celcuity Inc. | 3.21% |
| 6 | APLS | Apellis Pharmaceuticals, Inc. | 3.00% |
| 7 | SYRE | Spyre Therapeutics, Inc. | 2.89% |
| 8 | APGE | Apogee Therapeutics, Inc. | 2.85% |
| 9 | XENE | Xenon Pharmaceuticals Inc. | 2.84% |
| 10 | FOLD | Amicus Therapeutics, Inc. | 2.61% |
| 11 | DNTH | Dianthus Therapeutics, Inc. | 2.43% |
| 12 | CRNX | Crinetics Pharmaceuticals, Inc. | 2.39% |
| 13 | VKTX | Viking Therapeutics, Inc. | 2.36% |
| 14 | NAMS | NewAmsterdam Pharma Company N.V. | 2.28% |
| 15 | TVTX | Travere Therapeutics, Inc. | 2.23% |
| 16 | GPCR | Structure Therapeutics Inc. | 2.16% |
| 17 | ACAD | ACADIA Pharmaceuticals Inc. | 2.16% |
| 18 | EWTX | Edgewise Therapeutics, Inc. | 2.04% |
| 19 | ORKA | Oruka Therapeutics, Inc. | 1.87% |
| 20 | DNLI | Denali Therapeutics Inc. | 1.83% |
| 21 | VERA | Vera Therapeutics, Inc. | 1.82% |
| 22 | TARS | Tarsus Pharmaceuticals, Inc. | 1.81% |
| 23 | IDYA | IDEAYA Biosciences, Inc. | 1.63% |
| 24 | IRON | Disc Medicine, Inc. | 1.55% |
| 25 | RLAY | Relay Therapeutics, Inc. | 1.51% |
As of Apr 14, 2026